The Food and Drug Administration late Friday OK’d Qelbree (KELL’-bree) for treating attention deficit hyperactivity disorder in children ages 6 to 17.
But why ? Do we really need a new drug? Or any drug for that matter?
The following is a summary of the the article from ABS news.
It comes as a capsule that’s taken daily. The drug carries a warning of potential for suicidal thoughts and behavior, which occurred in fewer than 1% of volunteers in studies of the drug. It is not a stimulant or a controlled substance, making it harder to abuse than older drugs. ADHD affects about 6 million American children and adolescents. For many, problems include trouble paying attention and completing tasks, fidgeting and impulsiveness. It also could be an option for kids who have substance abuse problems, dislike the side effects of stimulants or need additional therapy.
But drugs for ADHD are not the right answer. Resonance Frequency Therapy for ADHD can address it with no drugs at all.